AlloEx exosomes

BIOLOGICAL2 trials

Sponsors

The Foundation for Orthopaedics and Regenerative Medicine

Conditions

Congenital Myasthenic SyndromeMotor Disorders

Phase 1

Patients With ALS and Other Motor Disorders Will be Treated With Mesenchymal Cell Exosome Solution

CompletedNCT07105371

The Foundation for Orthopaedics and Regenerative MedicineMotor Disorders

Start: 2024-07-14End: 2025-03-14Updated: 2025-08-22

Patients With Congenital Myasthenic Syndrome Will be Treated With Mesenchymal Stem Cell Exosome Solution

RecruitingNCT07226726

The Foundation for Orthopaedics and Regenerative MedicineCongenital Myasthenic Syndrome

Start: 2025-01-01End: 2028-12-31Target: 20Updated: 2025-11-10

Related Papers

Exosome-rich mesenchymal stem cell secretome improves strength in patients with amyotrophic lateral sclerosis, Kennedy disease, congenital myasthenic syndrome and Lewy body dementia.

2025-10-15